– CANADA, Vancouver – Aequus Pharmaceuticals Inc. (TSX: AQS | OTC: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced that, further to its news release on February 3, 2020, Stuart Fowler has now been formally appointed to its Board of Directors.
About Aequus Pharmaceuticals Inc.
Aequus Pharmaceuticals Inc. is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus has grown its pipeline to include several commercial products in ophthalmology and transplant, and a development stage pipeline in neurology.
For more information: https://aequuspharma.ca
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
